Classifications

• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B82—NANOTECHNOLOGY
  • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
  • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
  • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
  • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
  • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
  • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
  • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
  • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

• Chemical & Material Sciences (AREA)
• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Life Sciences & Earth Sciences (AREA)
• Medicinal Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Molecular Biology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Pharmacology & Pharmacy (AREA)
• Nanotechnology (AREA)
• Materials Engineering (AREA)
• Biotechnology (AREA)
• Public Health (AREA)
• Biochemistry (AREA)
• Animal Behavior & Ethology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Polymers & Plastics (AREA)
• Organic Chemistry (AREA)
• Biophysics (AREA)
• Veterinary Medicine (AREA)
• General Engineering & Computer Science (AREA)
• Medical Informatics (AREA)
• Crystallography & Structural Chemistry (AREA)
• Epidemiology (AREA)
• Medicinal Preparation (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Polysaccharides And Polysaccharide Derivatives (AREA)
• Medicines Containing Material From Animals Or Micro-Organisms (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Applications Claiming Priority (2)

Publications (2)

Family

ID=6217510

Family Applications (1)

Country Status (17)

Families Citing this family (131)

Family Cites Families (4)

• 1983
  • 1983-12-21 DE DE19833346123 patent/DE3346123A1/de not_active Withdrawn
• 1984
  • 1984-12-20 AU AU38352/85A patent/AU565966B2/en not_active Expired
  • 1984-12-20 EP EP84115965A patent/EP0149197B2/de not_active Expired - Lifetime
  • 1984-12-20 AT AT84115965T patent/ATE51145T1/de active
  • 1984-12-20 WO PCT/EP1984/000417 patent/WO1985002767A1/en active IP Right Grant
  • 1984-12-20 DE DE8484115965T patent/DE3481680D1/de not_active Expired - Lifetime
  • 1984-12-20 HU HU85795D patent/HU200943B/hu unknown
  • 1984-12-20 JP JP60500307A patent/JPS61500788A/ja active Granted
  • 1984-12-21 ZA ZA8410042A patent/ZA8410042B/xx unknown
  • 1984-12-21 CA CA000470876A patent/CA1222697A/en not_active Expired
• 1985
  • 1985-08-07 DK DK198503595A patent/DK175288B1/da active
  • 1985-08-20 FI FI853198A patent/FI86140C/fi active IP Right Grant
• 1993
  • 1993-03-04 SG SG248/93A patent/SG24893G/en unknown
  • 1993-11-25 HK HK1312/93A patent/HK131293A/xx not_active IP Right Cessation
• 1994
  • 1994-01-14 CY CY168994A patent/CY1689A/xx unknown
• 1998
  • 1998-02-26 NL NL980009C patent/NL980009I1/nl unknown
  • 1998-09-02 LU LU90283C patent/LU90283I2/fr unknown
• 2000
  • 2000-08-21 NO NO2000007C patent/NO2000007I1/no unknown

Also Published As

Similar Documents